Clinical trial specialist hVivo's H1 revenues jump by 30% Irish research and clinical trial specialist hVivo saw its revenues rise by over 30% in the first six months of the year to reach £35.6m. Business • 10 Sep 24
Clinical trial specialist hVivo's H1 revenues jump by 30% Irish research and clinical trial specialist hVivo saw its revenues rise by over 30% in the first six months of the year to reach £35.6m. Business • 10 Sep 24
hVivo expects half year revenues to rise by 30% Healthcare company hVIVO, formerly Open Orphan, said it expects to report first half revenues of £35.6m, which would represent 30.6% revenue growth on the same time last year Business • 17 Jul 24
hVivo expects half year revenues to rise by 30% Healthcare company hVIVO, formerly Open Orphan, said it expects to report first half revenues of £35.6m, which would represent 30.6% revenue growth on the same time last year Business • 17 Jul 24
Akkure raises €1m through crowdfunding campaign Irish medtech start-up Akkure has raised more than €1m in a week through a crowdfunding campaign. Business • 21 Nov 22
Akkure raises €1m through crowdfunding campaign Irish medtech start-up Akkure has raised more than €1m in a week through a crowdfunding campaign. Business • 21 Nov 22
Icon buys PRA Health Sciences in $12bn deal Irish contract research firm Icon is to buy rival PRA Health Sciences in a deal valued at about $12bn, expanding into virtual clinical trials that use patient data from mobile apps and wearable devices. Business • 24 Feb 21
Icon buys PRA Health Sciences in $12bn deal Irish contract research firm Icon is to buy rival PRA Health Sciences in a deal valued at about $12bn, expanding into virtual clinical trials that use patient data from mobile apps and wearable devices. Business • 24 Feb 21
Health service slow to adopt new medicines, says IPHA The Irish health system is slow to adopt new medicines despite the large pharma industry presence in the country, according to the Irish Phamaceutical Healthcare Association. Business • 13 Jan 20
Health service slow to adopt new medicines, says IPHA The Irish health system is slow to adopt new medicines despite the large pharma industry presence in the country, according to the Irish Phamaceutical Healthcare Association. Business • 13 Jan 20
